Rhenium re-188

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Rhenium re-188
DrugBank Accession Number
DB19267
Background

Rhenium re-188 is under investigation in clinical trial NCT03458559 (Rhenium-188-hedp vs. Radium-223-chloride in Patients With Advanced Prostate Cancer Refractory to Hormonal Therapy).

Type
Small Molecule
Groups
Investigational
Structure
Weight
Average: 187.9581
Monoisotopic: 187.958112287
Chemical Formula
Re
Synonyms
  • Rhenium-188
  • Rhenium, isotope of mass 188
External IDs
  • 188RE
  • Re 188

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
229C124H5I
CAS number
14378-26-8
InChI Key
WUAPFZMCVAUBPE-NJFSPNSNSA-N
InChI
InChI=1S/Re/i1+2
IUPAC Name
SMILES
[188Re]

References

General References
Not Available
ChemSpider
146188

Clinical Trials

Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package
PhaseStatusPurposeConditionsCountStart DateWhy Stopped100+ additional columns
3Unknown StatusTreatmentProstate Cancer Metastatic to Bone1somestatusstop reasonjust information to hide
2RecruitingTreatmentNon-Resectable Hepatocellular Carcinoma1somestatusstop reasonjust information to hide
1CompletedTreatmentHepatocellular Carcinoma1somestatusstop reasonjust information to hide
1CompletedTreatmentMetastatic Melanoma1somestatusstop reasonjust information to hide
0RecruitingTreatmentBreast Cancer / Radiotoxicity1somestatusstop reasonjust information to hide

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
Not Available

Drug created at July 12, 2024 16:45 / Updated at July 13, 2024 15:36